US 8969372
Aryl imidazoles and their use as anti-cancer agents
granted A61KA61K31/4178A61K31/4184
Quick answer
US patent 8969372 (Aryl imidazoles and their use as anti-cancer agents) held by Aptose Boisciences Inc. expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aptose Boisciences Inc.
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/4178, A61K31/4184, A61K31/4188, A61K31/4745